Deep learning to estimate RECIST in patients with NSCLC treated with PD-1 blockade

Real-world evidence (RWE) – conclusions derived from analysis of patients not treated in clinical trials – is increasingly recognized as an opportunity for discovery, to reduce disparities, and to contribute to regulatory approval. Maximal value of RWE may be facilitated through machine learning tec...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Discov
Main Authors: Arbour, Kathryn C., Luu, Anh Tuan, Luo, Jia, Rizvi, Hira, Plodkowski, Andrew J., Sakhi, Mustafa, Huang, Kevin B., Digumarthy, Subba R., Ginsberg, Michelle S., Girshman, Jeffrey, Kris, Mark G., Riely, Gregory J., Yala, Adam, Gainor, Justin F., Barzilay, Regina, Hellmann, Matthew D.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7981277/
https://ncbi.nlm.nih.gov/pubmed/32958579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-20-0419
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki